Skip to main content

Table 2 Myocardial infarction and mortality following joint surgery in patients with and without rheumatoid arthritis

From: Myocardial infarction and mortality following joint surgery in patients with rheumatoid arthritis: a retrospective cohort study

Outcome

RA (n = 3654)

Non-RA (n = 304,935)

Unadjusted ORa (95 % CI)

Adjusted ORab (95 % CI)

MI within 6 weeks

25 (0.68)

838 (0.27)

2.50 (1.68–3.73)

1.50 (0.96–2.33)

MI within 12 months

59 (1.61)

1968 (0.65)

2.53 (1.95–3.28)

1.70 (1.27–2.28)

All-cause death within 6 weeks

22 (0.60)

569 (0.19)

3.24 (2.11–4.97)

1.85 (1.09–3.13)

All-cause death within 12 months

93 (2.55)

2411 (0.79)

3.28 (2.66–4.04)

2.18 (1.66–2.86)

CV death within 6 weeks

15 (0.41)

372 (0.12)

3.37 (2.01–5.66)

1.90 (1.07–3.37)

CV death within 12 months

61 (1.67)

1406 (0.46)

3.67 (2.83–4.75)

2.30 (1.65–3.22)

  1. Values for RA and Non-RA are the number (%) of episodes. aReference group patients without rheumatoid arthritis; badjusted for age, sex, comorbidities, admission type (emergency vs elective), patient type (public vs private), socioeconomic status and joint surgery type (hip, knee, ankle and shoulder joint arthroplasty/arthrodesis vs all other). MI myocardial infarction, CV cardiovascular, RA rheumatoid arthritis, O, odds ratio; CI confidence interval. Results in italics are statistically significant